India May Approve Russia’s Sputnik V Vaccine in Next Few Weeks

Indian watchdog may approve Russia’s coronavirus vaccine Sputnik V in the next few weeks, after which its production in India may be set up, Indian Ambassador in Moscow Venkatesh Varma told Sputnik on Monday.

According to the diplomat, the vaccine is going through trials in India.

The vaccine’s production in India will be discussed during the visit of Indian deputy foreign minister to Moscow, expected to take place on Wednesday and Thursday.

Sputnik V, developed by the Gamaleya Epidemiology and Microbiology Centre, was the world’s first vaccine against COVID-19 and was registered by the Russian health ministry on 11 August. To date, SPutnik V has been authorised in 26 countries, according to the Russian Direct Investment Fund.